1. Home
  2. NATH vs RAPP Comparison

NATH vs RAPP Comparison

Compare NATH & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NATH
  • RAPP
  • Stock Information
  • Founded
  • NATH 1916
  • RAPP 2022
  • Country
  • NATH United States
  • RAPP United States
  • Employees
  • NATH N/A
  • RAPP N/A
  • Industry
  • NATH Restaurants
  • RAPP
  • Sector
  • NATH Consumer Discretionary
  • RAPP
  • Exchange
  • NATH Nasdaq
  • RAPP Nasdaq
  • Market Cap
  • NATH 411.9M
  • RAPP 439.4M
  • IPO Year
  • NATH N/A
  • RAPP 2024
  • Fundamental
  • Price
  • NATH $105.32
  • RAPP $14.71
  • Analyst Decision
  • NATH
  • RAPP Strong Buy
  • Analyst Count
  • NATH 0
  • RAPP 3
  • Target Price
  • NATH N/A
  • RAPP $33.67
  • AVG Volume (30 Days)
  • NATH 37.4K
  • RAPP 162.2K
  • Earning Date
  • NATH 08-08-2025
  • RAPP 08-07-2025
  • Dividend Yield
  • NATH 1.90%
  • RAPP N/A
  • EPS Growth
  • NATH 9.62
  • RAPP N/A
  • EPS
  • NATH 5.77
  • RAPP N/A
  • Revenue
  • NATH $150,413,000.00
  • RAPP N/A
  • Revenue This Year
  • NATH N/A
  • RAPP N/A
  • Revenue Next Year
  • NATH N/A
  • RAPP N/A
  • P/E Ratio
  • NATH $18.26
  • RAPP N/A
  • Revenue Growth
  • NATH 6.38
  • RAPP N/A
  • 52 Week Low
  • NATH $73.00
  • RAPP $6.43
  • 52 Week High
  • NATH $118.50
  • RAPP $29.74
  • Technical
  • Relative Strength Index (RSI)
  • NATH 57.57
  • RAPP N/A
  • Support Level
  • NATH $101.22
  • RAPP N/A
  • Resistance Level
  • NATH $101.18
  • RAPP N/A
  • Average True Range (ATR)
  • NATH 3.11
  • RAPP 0.00
  • MACD
  • NATH 1.24
  • RAPP 0.00
  • Stochastic Oscillator
  • NATH 96.16
  • RAPP 0.00

About NATH Nathan's Famous Inc.

Nathan's Famous Inc is an owner of fast food franchises in the United States. The company's reportable segment includes the Branded Product Program, Product licensing, Restaurant operations and Corporate. Branded Product Program derives revenue principally from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors who resell the products to foodservice operators. It generates maximum revenue from the Branded Product Program segment. Geographically, it derives a majority of revenue from the United States.

About RAPP Rapport Therapeutics Inc. Common Stock

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: